Header Logo

Connection

LORETTA NASTOUPIL to Drugs, Investigational

Back to Details
This is a "connection" page, showing publications LORETTA NASTOUPIL has written about Drugs, Investigational.
LORETTA NASTOUPIL
Connection Strength
0.049
Drugs, Investigational
  1. Early drug development in solid tumours: analysis of National Cancer Institute-sponsored phase 1 trials. Lancet. 2022 08 13; 400(10351):512-521.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.